GLENMARK PHARMACEUTICALS USA for GLENMARK PHARMACEUTICALS USA
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
HR 938, BLOCKING Act, issues related to pharmaceutical manufacturing supply chain
Foreign entity interest: Glenmark Pharmaceuticals Inc. USA (GPI) is the North American division of Glenmark Pharmaceuticals, Ltd. (GPL), a corporation formed under the laws of India. GPL, as GPIs upstream foreign parent, has an interest in the listed issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GRANT ERDEL | — |
Medicare/Medicaid MMM
Medicaid Generics Penalty
Foreign entity interest: Glenmark Pharmaceuticals Inc. USA (GPI) is the North American division of Glenmark Pharmaceuticals, Ltd. (GPL), a corporation formed under the laws of India. GPL, as GPIs upstream foreign parent, has an interest in the listed issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GRANT ERDEL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.